Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies

Weight Watchers expanded its GLP-1 weight-loss medication access by joining Eli Lilly's LillyDirect platform, combining branded medications with clinical support. Meanwhile, Eli Lilly partnered with Ascidian Therapeutics on RNA-based kidney disease treatments with potential deal value reaching $1.9 billion. Eli Lilly shares surged 5.13% to $1,134.08.

06/04/2026, 12:17 PM • Benzinga

Weight Watchers Announces Leadership Transition and Board Updates

Weight Watchers (WW) announced that CEO Tara Comonte departed effective March 31, 2026. The company established an Office of the CEO led by CFO Felicia DellaFortuna and COO Jon Volkmann, with an interim CEO to be appointed. A Transition Committee was formed to oversee operations and conduct a comprehensive CEO search. The company reaffirmed its Q1 2026 subscriber estimates and full year 2026 financial guidance. Additionally, Debra Cotter was appointed as chief legal officer, and two board directors resigned.

04/03/2026, 2:09 PM • GlobeNewswire

Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings.

Amazon has entered the GLP-1 weight loss drug market by offering Novo Nordisk's Wegovy pill through its pharmacy service at competitive prices ($25-$149 per month). This move could significantly impact competitors like Hims & Hers, WW International, and GoodRx, as Amazon leverages its 200 million Prime members and e-commerce platform. While the pill form is expected to drive overall GLP-1 adoption, Amazon's scale and reach pose a competitive threat to specialized GLP-1 retailers.

02/05/2026, 8:15 PM • The Motley Fool

Weight Watchers to Participate in Upcoming Investor Conferences

WW International announced its participation in two investor conferences in January 2026: the ICR Conference (January 12-13) in Orlando, FL and CJS Securities' 26th Annual New Ideas for the New Year (January 14) with a virtual fireside chat. The company will host investor meetings at both events.

01/07/2026, 9:00 AM • GlobeNewswire

Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost

Novo Nordisk launched its Wegovy weight loss pill in US pharmacies in December 2025 with competitive pricing starting at $149/month for self-pay patients. The pill demonstrated 17% average weight loss versus 3% for placebo. It's available through major retailers including CVS and Costco, as well as telehealth providers. Despite the positive product launch, NVO stock remains down 35.61% over the past year and trades 8.4% below its 200-day moving average.

01/05/2026, 12:23 PM • Benzinga

Weight Management Market Outlook to 2030: 7.6% CAGR as Digital Adoption Rises and Preventive Health Focus Strengthens, Says Mordor Intelligence

The global weight management market is valued at USD 39.07 billion in 2025 and is projected to reach USD 60.48 billion by 2030, growing at a 7.6% CAGR. Growth is driven by rising obesity prevalence, digital platform adoption, and a shift toward holistic, sustainable weight management programs. North America leads the market while Asia-Pacific is the fastest-growing region.

12/24/2025, 5:05 AM • GlobeNewswire

Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Programme

WeightWatchers introduces a specialized menopause program offering personalized medical care, nutrition guidance, and community support, with Queen Latifah as its spokesperson to address women's health needs during menopause.

09/08/2025, 8:54 AM • GlobeNewswire

Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Program

WeightWatchers introduces a comprehensive menopause program targeting women's health, featuring Queen Latifah as spokesperson. The program offers personalized medical care, nutrition guidance, and community support specifically designed for women experiencing perimenopause and postmenopause.

09/08/2025, 8:50 AM • GlobeNewswire

WeightWatchers treibt internationales Wachstum mit strategischer Verstärkung im Führungsteam voran

WeightWatchers appointed Alejandro Bethlen as Executive Vice President International to lead global expansion and innovation, leveraging his extensive experience in global business development across consumer and e-commerce sectors.

09/03/2025, 4:00 AM • GlobeNewswire

WeightWatchers Advances International Growth With Strategic Leadership Appointment

WeightWatchers appointed Alejandro Bethlen as Executive Vice President, International, to drive global growth and innovation. Bethlen brings extensive experience from Zooplus, Amazon, and other consumer-focused companies to expand the company's international presence.

09/03/2025, 4:00 AM • GlobeNewswire

WeightWatchers Appoints SoulCycle Co-Founder Julie Rice as Chief Experience Officer to Lead Community and Brand Innovation

WeightWatchers has appointed Julie Rice, co-founder of SoulCycle, as its new Chief Experience Officer to lead community and brand innovation, focusing on enhancing member support and transforming the company's global workshop business.

08/07/2025, 10:58 AM • GlobeNewswire

WeightWatchers Reschedules Second Quarter 2025 Earnings Release and Conference Call to Finalize Fresh Start Accounting Adoption in Connection with Emergence

WeightWatchers has rescheduled its Q2 2025 earnings release to August 11, 2025, to finalize Fresh Start Accounting following its financial reorganization process completed on June 24, 2025.

08/04/2025, 5:38 PM • GlobeNewswire